Do Not Trade This! I'd personally wait for a retest around $6.90 before making my move. Might buy a few shares for fun tomorrow and see how it rolls. For premium crypto & option signals, direct message me or @Kyer DotcomJack | Easy Loot
MOH (Biotech stock) has been consolidating tightly at ATH. There is clear R/S in this name despite the recent market weakness. On the 65m chart, MOH cleared the HVN above 172 and looks primed for continuation next week. Went long at the HVN break and above the intraday higher high. Entry - 172.96 Stop Loss - 165 Target - 200 I will continue to update this...
Contextual immersion trading strategy idea. Synlogic is a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. The demand for shares of the company looks higher than the supply. These and other conditions can cause a rise in...
Ghsi looks to be retracing, imo will retrace to 0.3412. then i am looking for a bounce to go long. Dependant on whether it is able to maintain key levels and break through the triangle. Looking to add to my positions soon and hold until PT is hit.
All, This is a GREAT stock that has an extremely clear bottom and only $7 which means options and just buy and selling is easy. Right now it is extremely obvious. Buy in around $4 to $4.75 UNLESS it breaks this upper resistance, but even if it does there are some resistance levels $9-$11 range. So I would be careful if you are bullish where it is at now.
INCY broke the resistance with great volume. After long rally, it is maybe time to pull back. Watch for RSI
APTO Buy and Sell zones on a trend reversal could be cup and handle obviously a double bottom. If it holds this higher uptrend support and not the channel a breakout is still a buy above obviously
I actually trade this for 15-20% gains on deep supply zones. Last time I got in was .51 so not bad if you understand where to buy in. I like the swings in this stock and has some volume. Bullish weekly at least to start off next week. Might fail right away with the resistance and the highs. Just need a solid open above .73. Still not banking on that. Just wanted...
Contextual immersion trading strategy idea. Cidara Therapeutics is a biotechnology company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases The demand for shares of the company looks higher than the supply. Due to the spread of COVID-19, the demand for the company`s services rose. This and...
Novavax's Nanoflu isn't your typical new drug-- it's a whole new pharmaceutical technology. So it's hard to overstate how important today's positive Phase 3 clinical trial result is. Positive Phase 3 trial data this morning suggest that Novavax's Virus-Like Particle (VLP)-based flu vaccines will be much more effective than existing egg-based vaccines. When you...
Contextual immersion trading strategy idea. Chiasma focuses on developing oral medications using a transient permeability enhancer technology platform for the treatment of rare and serious chronic diseases. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I...
NASDAQ:GILD $GILD - I Mean Come On! #SuperSimpleCharts
Contextual immersion trading strategy idea. The demand for shares of Immunomedics looks higher than the supply. It is a clinical-stage biopharmaceutical company, which develops monoclonal antibody-based products for the targeted treatment of cancer. On 06APR the company announced that its Phase 3 confirmatory ASCENT study will be halted due to compelling...
Contextual immersion trading strategy idea. The demand for shares of China Biologic Products Holdings looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $99,86; stop-loss — $102,65. Information about take-profits will be later. Do not view this idea as a recommendation...
ACST has been in a rising wedge in a bullish pattern and high buy volume. Still long